Ischemic StrokeSleep SMARTNCT03812653
Sleep for Stroke Management and Recovery Trial
A study testing CPAP in people with Ischemic Stroke and Sleep Apnea, run by University of Michigan at 116 sites in United States.
Trial summary
The purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ischemic stroke (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Ischemic Stroke, Sleep Apnea, Sleep Apnea, Obstructive
- What is being tested?
- CPAP
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 3,062 participants
- Where
- 116 sitesUnited States
- Study dates
- 9 May 2019to Nov 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
None listed.
Who cannot join
- pre-event inability to perform all of own basic ADLs
- unable to obtain informed consent from subject or legally authorized representative
- incarcerated
- known pregnancy
- current mechanical ventilation (can enroll later if this resolves) or tracheostomy
- current use of positive airway pressure, or use within one month prior to stroke
Show all 16Show fewer
- anatomical or dermatologic anomaly that makes use of CPAP interface unfeasible
- severe bullous lung disease
- history of prior spontaneous pneumothorax or current pneumothorax
- hypotension requiring current treatment with pressors (can enroll later if this resolves)
- other specific medical circumstances that conceivably, in the opinion of the site PI, could render the patient at risk of harm from use of CPAP
- massive epistaxis or previous history of massive epistaxis
- cranial surgery or head trauma within the past 6 months, with known or possible CSF leak or pneumocephalus
- recent hemicraniectomy or suboccipital craniectomy (i.e. those whose bone has not yet been replaced), or any other recent bone removal procedure for relief of intracranial pressure
- current receipt of oxygen supplementation >4 liters per minute
- current contact, droplet, respiratory/airborne precautions
Trial locations and contacts
116 sites in 1 country.
116 sites in 1 country
United States116 sites
University of New Mexico Hospital
Albuquerque, New Mexico, 87106
Grady Memorial Hospital
Atlanta, Georgia, 30303
University of Maryland
Baltimore, Maryland, 21201
St. Luke's University Hospital Bethlehem Campus
Bethlehem, Pennsylvania, 18015
University of Alabama Hospital
Birmingham, Alabama, 35294
Tufts Medical Center
Boston, Massachusetts, 02111
Massachusetts General Hospital
Boston, Massachusetts, 02114
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215
Maimonides Medical Center
Brooklyn, New York, 11219
NYU Langone Brooklyn
Brooklyn, New York, 11220
Buffalo General Medical Center
Buffalo, New York, 14203
The University of Vermont Medical Center Main Campus
Burlington, Vermont, 05401
Mercy San Juan Medical Center
Carmichael, California, 95608
Chandler Regional Medical Center
Chandler, Arizona, 85224
Carolinas Medical Center Atrium Health
Charlotte, North Carolina, 28203
UVA Medical Center
Charlottesville, Virginia, 22908
Rush University Medical Center
Chicago, Illinois, 60612
University of Illinois Hospital and Health Sciences System
Chicago, Illinois, 60612
University of Chicago
Chicago, Illinois, 60637
Christ Hospital
Cincinnati, Ohio, 45219
University of Cincinnati Medical Center
Cincinnati, Ohio, 45219
Morton Plant Hospital
Clearwater, Florida, 33756
UH Cleveland Medical Center
Cleveland, Ohio, 11100
Cleveland Clinic
Cleveland, Ohio, 44195
Palmetto Health Richland
Columbia, South Carolina, 29203
OSU Wexner Medical Center
Columbus, Ohio, 43210
Carolinas Rehab Northeast
Concord, North Carolina, 28025
Baylor Scott & White Institute of Rehabilitation
Dallas, Texas, 75246
Geisinger Clinic
Danville, Pennsylvania, 17822
Iowa Methodist
Des Moines, Iowa, 50309
Henry Ford Hospital
Detroit, Michigan, 48202
Rancho Los Amigos National Rehabilitation Center
Downey, California, 90242
JFK Neuroscience Institute
Edison, New Jersey, 08820
Inova Fairfax
Falls Church, Virginia, 22042
McLaren Flint
Flint, Michigan, 48532
Broward Health
Fort Lauderdale, Florida, 33305
UF Health Shands Hospital
Gainesville, Florida, 32611
St. Mary's Hospital and Medical Center
Grand Junction, Colorado, 81501
Trinity Health Saint Mary's
Grand Rapids, Michigan, 49503
Guilford Neurologic Associates, Inc
Greensboro, North Carolina, 27401
Greenville Memorial Hospital
Greenville, South Carolina, 29605
Hartford Hospital
Hartford, Connecticut, 06102
Penn State Milton S. Hershey Center
Hershey, Pennsylvania, 17033
Memorial Hermann Texas Medical Center
Houston, Texas, 77030
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242
University of Mississippi Medical Center
Jackson, Mississippi, 39216
UF Jacksonville
Jacksonville, Florida, 32209
Brooks Rehabilitation Hospital
Jacksonville, Florida, 32216
Bronson Methodist Hospital
Kalamazoo, Michigan, 49008
Saint Luke's Hospital of Kansas City
Kansas City, Missouri, 64111
Fort Sanders Regional Medical Center
Knoxville, Tennessee, 37916
Gundersen Lutheran Medical Foundation
La Crosse, Wisconsin, 54601
Scripps Memorial
La Jolla, California, 92037
UCSD Health La Jolla
La Jolla, California, 92103
Cooperman Barnabas Medical Center
Livingston, New Jersey, 07039
Cedars-Sinai Medical Center
Los Angeles, California, 90048
Ronald Reagan UCLA Medical Center
Los Angeles, California, 90095
Kaiser Permanente Los Angeles
Los Angeles, California, 94612
Norton HealthCare
Louisville, Kentucky, 40218
University of Wisconsin University Hospital
Madison, Wisconsin, 53715
North Shore University Hospital
Manhasset, New York, 11030
Methodist University
Memphis, Tennessee, 38105
Jackson Memorial Hospital
Miami, Florida, 33136
Baptist Hospital of Miami
Miami, Florida, 33176
Doctors Medical Center of Modesto
Modesto, California, 95355
Ruby Memorial Hospital
Morgantown, West Virginia, 26506
Intermountain Medical Center
Murray, Utah, 84107
Hackensack Meridian Jersey Shore University Medical Center
Neptune City, New Jersey, 07753
Yale-New Haven Hospital
New Haven, Connecticut, 06510
Ochsner Medical Center - Main Campus
New Orleans, Louisiana, 70121
Bellevue Hospital
New York, New York, 10016
NYU Langone -Tish Hospital Medical Center
New York, New York, 10016
NYP Columbia University Medical Center
New York, New York, 10032
University of Nebraska Medical Center
Omaha, Nebraska, 68198
UCLA Kaiser Fontana
Ontario, California, 91761
UC Irvine
Orange, California, 92868
OSF Saint Francis Medical Center
Peoria, Illinois, 61603
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104
Temple University Hospital
Philadelphia, Pennsylvania, 19122
Banner University Medical Center Phoenix
Phoenix, Arizona, 85006
Dignity Health - St. Joseph's Hospital and Medical Center
Phoenix, Arizona, 85013
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania, 15213
Casa Colina
Pomona, California, 91767
Providence St. Vincent Medical Center
Portland, Oregon, 97225
Kaiser Redwood
Redwood City, California, 94063
Virginia Commonwealth University
Richmond, Virginia, 23219
Mayo Clinic Saint Marys Campus
Rochester, Minnesota, 55905
Strong Memorial Hospital
Rochester, New York, 14642
UC Davis Medical Center
Sacramento, California, 95817
Saint Cloud/Centracare Health
Saint Cloud, Minnesota, 56303
University of Utah Healthcare
Salt Lake City, Utah, 84132
UCSD Medical Center - Hillcrest Hospital
San Diego, California, 92103
UCSF Helen Diller Medical Center at Parnassus Heights
San Francisco, California, 94143
Orange County Global Medical Center
Santa Ana, California, 92705
Sarasota Memorial Hospital
Sarasota, Florida, 34239
Virginia Mason Medical Center
Seattle, Washington, 98101
Harborview Medical Center
Seattle, Washington, 98195
University Health Shreveport
Shreveport, Louisiana, 71103
Avera Research Institute
Sioux Falls, South Dakota, 57108
Memorial Medical Center
Springfield, Illinois, 62702
Cox Medical Center
Springfield, Missouri, 65807
Barnes-Jewish Hospital
St Louis, Missouri, 63110
Staten Island University Hospital
Staten Island, New York, 10305
Olive View- UCLA Medical Center
Sylmar, California, 91342
Suny Upstate Medical University
Syracuse, New York, 13210
Tampa General Hospital
Tampa, Florida, 33606
St. Joseph's Hospital
Tampa, Florida, 33607
Montefiore Medical Center
The Bronx, New York, 10467
TMC Healthcare
Tucson, Arizona, 85712
Banner- University Medical Center Tucson
Tucson, Arizona, 85719
St. John Health System
Tulsa, Oklahoma, 74104
John Muir Medical Center- Walnut Creek Campus
Walnut Creek, California, 94598
George Washington University Hospital
Washington D.C., District of Columbia, 20037
West Chester Hospital
West Chester, Ohio, 45069
Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, 27157
UMass Memorial Medical Center,
Worcester, Massachusetts, 01655
About this study
The purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ischemic stroke (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke.
Read the detailed description
Sleep SMART has a prospective, randomized, open-label, blinded-endpoint (PROBE) design. It is a multi-site, parallel-group superiority trial that compares 6 months of OSA treatment to usual care. The study includes two trials: a prevention study with an embedded recovery trial. 3062 subjects will be randomized over 5 years at 110 sites within the NINDS-funded StrokeNet clinical trials network.
- Conditions
- Ischemic Stroke, Sleep Apnea, Sleep Apnea, Obstructive, Stroke, CPAP, Telemedicine
- Being tested
- CPAP
- Medical subject headings
- Ischemic Stroke, Sleep Apnea Syndromes, Sleep Apnea, Obstructive, Stroke
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
CPAPDevice
Automatically-adjusting continuous positive airway pressure (CPAP) delivered using a study supplied device.
| Study group | Role | What they receive |
|---|---|---|
| Intervention Arm: CPAP with Usual Care. | Experimental | 6 months of CPAP plus usual medical therapy. Receives: Device: CPAP |
| Control Arm: Usual Care. | No intervention | 6 months of usual medical therapy alone. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Time to Event Combined Outcome: new ischemic stroke, acute coronary syndrome, or all-cause mortality
The primary outcome is a time-to-event outcome defined as a participant having at least one of the following events within 6-months from randomization: new ischemic stroke, acute coronary syndrome or all-cause mortality
Measured: 6 months post randomization
Modified Rankin Scale Score
Functional outcome as measured by the 9 question modified Rankin Scale (mRS-9Q). The mRS-9Q has 9 questions related to level of function. Outcomes range from 0 (no symptoms) to 6 (death).
Measured: 3 months post randomization
Secondary outcomes (3)
NIH Stroke Score (NIHSS)
Neurological outcome is measured by the NIHSS. The NIHSS scale ranges from 0 (no deficits) to 42.
Measured: 3 months post randomization
Short Montreal Cognitive Assessment (MoCA) Score
Cognitive outcome is measured by the Short MoCA. The short MoCA is a 5 minute short version of the Montreal Cognitive Assessment (MoCA). This instrument tests phonemic verbal fluency (1 point), delayed recall (5 points), and orientation (6 points) with a score ranging from 0-12.
Measured: 3 months post randomization
Quality of Life outcome
Quality of life outcome is measured by the shortened Stroke Specific Quality of Life Scale (SS-QOL). The short SS-QOL has 7 domains that include physical function, language, vision, thinking, energy, mood, and role function. There is 1 question from each domain. The 12 item SS-QOL is calculated by averaging the scores of these 12 questions.
Measured: 3 months post randomization
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jan 2019
- Study start9 May 2019
- Primary completionNov 2026 (estimated)
- Study completionNov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Ischemic StrokeStudies of the same condition, open and under way.
- More trials run by University of MichiganThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Intervention group receives automatically adjusting continuous positive airway pressure (CPAP) plus usual care.The control group receives usual care.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 3,062 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Michigan
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute of Neurological Disorders and Stroke (NINDS), FusionHealth LLC, Medical University of South Carolina, University of Cincinnati
- Responsible party
- Principal investigator, Devin L. Brown, MD, University of Michigan
- Investigators
- Devin Brown, MD, MS, Principal investigator, University of MichiganRonald Chervin, MD, MS, Principal investigator, University of Michigan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03812653
- Sponsor's protocol ID
- HUM00147316
- Other IDs
- 1U01NS099043-01A1
- Acronym
- Sleep SMART
- Status last verified
- Jan 2026
- First submitted
- 18 Jan 2019
- Last updated
- 2 Feb 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- Yes: We will comply with the NIH Data Sharing Policy, Policy on the Dissemination of NIH-Funded Clinical Trial Information, the Clinical Trials Registration and Results Information Submission rule, and StrokeNet SOP on Network Data Sharing Policy. NDMC statisticians will generate data files from each data table and in compliance with HIPAA regulations each table will be de-identified. A minimum number of derived variables necessary to reproduce the primary analysis will be created. Within a year from acceptance of the primary manuscript or no later than two years from database lock, the public-use data sets will be submitted to the NINDS data repository along with final version of the study protocol, data dictionary and a user guide. Data along with signals from sleep apnea recordings will be submitted to the NHLBI National Sleep Research Resource.
Publications
Brown DL, Durmer JS, Aloia M, Hankla RM, Novitski K, Sickler JB, Considine S, Delacroix E, Ong JC, Baran AS, Anderson CS, Bravata DM, Yaggi HK, Durkalski-Mauldin V, Chervin RD. A multilevel CPAP support strategy implemented within a large stroke clinical trial (sleep SMART). Front Sleep. 2026 May 25;5:1832143. doi: 10.3389/frsle.2026.1832143. eCollection 2026.
PubMed 42266869Brown DL, Novitski K, Sickler JB, Hankla RM, Khattak F, Philpot E, Durkalski-Mauldin V, Sayyahmelli S, Patino C, Arevalo-Bermudez F, Roberts M, Sahelian A, Chervin RD. Use of a Generative Pretrained Transformer to Answer Questions and Facilitate a Large Randomized Controlled Trial. J Am Heart Assoc. 2025 Oct 21;14(20):e043333. doi: 10.1161/JAHA.125.043333. Epub 2025 Oct 21.
PubMed 41120814
Study at a glance
From the registry record, last updated by the sponsor on 2 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Sleep for Stroke Management and Recovery Trial
- ClinicalTrials.gov ID
- NCT03812653
- Acronym / sponsor ID
- Sleep SMART / HUM00147316
- Conditions
- Ischemic Stroke, Sleep Apnea, Sleep Apnea, Obstructive, Stroke, CPAP, Telemedicine
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 3,062 participants (estimated)
- Lead sponsor
- University of MichiganUniversity, hospital or other
- Collaborators
- National Institute of Neurological Disorders and Stroke (NINDS), FusionHealth LLC, Medical University of South Carolina, University of Cincinnati
- Study start
- 9 May 2019 (actual)
- Primary completion
- Nov 2026 (estimated)
- Study completion
- Nov 2026 (estimated)
- First posted
- 23 Jan 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ischemic stroke (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke.
Detailed description
Sleep SMART has a prospective, randomized, open-label, blinded-endpoint (PROBE) design. It is a multi-site, parallel-group superiority trial that compares 6 months of OSA treatment to usual care. The study includes two trials: a prevention study with an embedded recovery trial. 3062 subjects will be randomized over 5 years at 110 sites within the NINDS-funded StrokeNet clinical trials network.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Intervention group receives automatically adjusting continuous positive airway pressure (CPAP) plus usual care.The control group receives usual care.
| Arm | Type | Receives |
|---|---|---|
| Intervention Arm: CPAP with Usual Care. | Experimental | Device: CPAP6 months of CPAP plus usual medical therapy. |
| Control Arm: Usual Care. | No intervention | –6 months of usual medical therapy alone. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (0 listed)
Key exclusion criteria (16 listed)
- pre-event inability to perform all of own basic ADLs
- unable to obtain informed consent from subject or legally authorized representative
- incarcerated
- known pregnancy
- current mechanical ventilation (can enroll later if this resolves) or tracheostomy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| CPAPAutomatically-adjusting continuous positive airway pressure (CPAP) delivered using a study supplied device. | Device | Intervention Arm: CPAP with Usual Care. |
Primary outcome
Time to Event Combined Outcome: new ischemic stroke, acute coronary syndrome, or all-cause mortality
Time frame: 6 months post randomization
The primary outcome is a time-to-event outcome defined as a participant having at least one of the following events within 6-months from randomization: new ischemic stroke, acute coronary syndrome or all-cause mortality
Modified Rankin Scale Score
Time frame: 3 months post randomization
Functional outcome as measured by the 9 question modified Rankin Scale (mRS-9Q). The mRS-9Q has 9 questions related to level of function. Outcomes range from 0 (no symptoms) to 6 (death).
3 secondary outcomes
NIH Stroke Score (NIHSS)
Time frame: 3 months post randomization
Short Montreal Cognitive Assessment (MoCA) Score
Time frame: 3 months post randomization
Quality of Life outcome
Time frame: 3 months post randomization
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Feb 2026.
- Derived from this study: PubMed 42266869Brown DL, Durmer JS, Aloia M, Hankla RM, Novitski K, Sickler JB, Considine S, Delacroix E, Ong JC, Baran AS, Anderson CS, Bravata DM, Yaggi HK, Durkalski-Mauldin V, Chervin RD. A multilevel CPAP support strategy implemented within a large stroke clinical trial (sleep SMART). Front Sleep. 2026 May 25;5:1832143. doi: 10.3389/frsle.2026.1832143. eCollection 2026.
- Derived from this study: PubMed 41120814Brown DL, Novitski K, Sickler JB, Hankla RM, Khattak F, Philpot E, Durkalski-Mauldin V, Sayyahmelli S, Patino C, Arevalo-Bermudez F, Roberts M, Sahelian A, Chervin RD. Use of a Generative Pretrained Transformer to Answer Questions and Facilitate a Large Randomized Controlled Trial. J Am Heart Assoc. 2025 Oct 21;14(20):e043333. doi: 10.1161/JAHA.125.043333. Epub 2025 Oct 21.
- Individual participant dataSharing planned: Yes. We will comply with the NIH Data Sharing Policy, Policy on the Dissemination of NIH-Funded Clinical Trial Information, the Clinical Trials Registration and Results Information Submission rule, and StrokeNet SOP on Network Data Sharing Policy. NDMC statisticians will generate data files from each data table and in compliance with HIPAA regulations each table will be de-identified. A minimum number of derived variables necessary to reproduce the primary analysis will be created. Within a year from acceptance of the primary manuscript or no later than two years from database lock, the public-use data sets will be submitted to the NINDS data repository along with final version of the study protocol, data dictionary and a user guide. Data along with signals from sleep apnea recordings will be submitted to the NHLBI National Sleep Research Resource.
Related trials for Ischemic Stroke
Not yet recruiting
Temporal Interference Stimulation for Upper-Limb Motor Recovery in Early Subacute Stroke
Acute Ischemic Stroke
RecruitingObservational study
ELATE Study: Evaluating Large-vessel Acute Thrombectomy in Extended Time Window
Acute Ichemic Stroke
Not yet recruiting
Selective Intra-Arterial Hypothermia After Endovascular Treatment for Acute Basilar Artery Occlusion
Acute Ischemic Stroke, Basilar Artery Occlusion
Active, not recruiting
Improving Visual Field Deficits With Noninvasive Brain Stimulation
Visual Field Defect, Peripheral, Stroke
Recruiting
Biomarkers of Paired VNS
Stroke, Ischemic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Devin Brown, MD, MS principal investigator
University of Michigan
Ronald Chervin, MD, MS principal investigator
University of Michigan
116 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing CPAP in people with Ischemic Stroke and Sleep Apnea, run by University of Michigan at 116 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 0 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 2 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 116 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time to Event Combined Outcome: new ischemic stroke, acute coronary syndrome, or all-cause mortality (time frame: 6 months post randomization). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03812653, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Feb 2026.